Clinical trial
Noninvasive Brain Stimulation Therapy in Subacute Human Spinal Cord Injury: A Translational Study
NCT06247904 is registered in ClinicalTrials.gov with Albert Einstein Healthcare Network as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Noninvasive Brain Stimulation Therapy in Subacute Human Spinal Cord Injury: A Translational Study
- Lead sponsor
- Albert Einstein Healthcare Network
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- April 9, 2025
- Completion date
- May 31, 2026
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
tetraplegia/tetraparesis, traumatic spinal cord injury